Related references
Note: Only part of the references are listed.Surgical indication for and desirable outcomes of conversion surgery in patients with initially unresectable pancreatic ductal adenocarcinoma
Sohei Satoi et al.
ANNALS OF GASTROENTEROLOGICAL SURGERY (2020)
Conversion surgery only for highly selected patients with unresectable pancreatic cancer: a satisfactory outcome in exchange for a lower resection rate
Seiji Natsume et al.
SURGERY TODAY (2019)
CT response of primary tumor and CA19-9 predict resectability of metastasized pancreatic cancer after FOLFIRINOX
Masayuki Tanaka et al.
EJSO (2019)
Conversion surgery for initially unresectable pancreatic cancer: current status and unresolved issues
Hideyuki Yoshitomi et al.
SURGERY TODAY (2019)
Second-Line Gemcitabine Plus Nab-Paclitaxel for Patients with Unresectable Advanced Pancreatic Cancer after First-Line FOLFIRINOX Failure
Naoki Mita et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer
Junji Furuse et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2018)
Clinical outcomes of FOLFIRINOX in locally advanced pancreatic cancer A single center experience
Jongchan Lee et al.
MEDICINE (2018)
A multicenter prospective phase II study of first-line modified FOLFIRINOX for unresectable advanced pancreatic cancer
Kensaku Yoshida et al.
ONCOTARGET (2017)
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma
Eran Sadot et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Resectability After First-Line FOLFIRINOX in Initially Unresectable Locally Advanced Pancreatic Cancer: A Single-Center Experience
Ulrich Nitsche et al.
ANNALS OF SURGICAL ONCOLOGY (2015)
Role of adjuvant surgery in initially unresectable pancreatic cancer after long-term chemotherapy or chemoradiation therapy: survival benefit?
Singh Sapam Opendro et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2014)
Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery
Sohei Satoi et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2013)
Increased Survival in Pancreatic Cancer with nab-Paclitaxel plus Gemcitabine
Daniel D. Von Hoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Downstaging in Pancreatic Cancer: A Matched Analysis of Patients Resected Following Systemic Treatment of Initially Locally Unresectable Disease
K. A. Bickenbach et al.
ANNALS OF SURGICAL ONCOLOGY (2012)
Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy
Kentaro Kato et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2011)
FOLFIRINOX versus Gemcitabine for Metastatic Pancreatic Cancer
Thierry Conroy et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Classification of surgical complications - A new proposal with evaluation in a cohort of 6336 patients and results of a survey
D Dindo et al.
ANNALS OF SURGERY (2004)
Share Paper
